Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31,689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.
Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ 3rd, Benson JT, Colby CL, Dispenzieri A, Landgren O, Kumar S, Bradwell AR, Cerhan JR, Rajkumar SV. Katzmann JA, et al. Among authors: kumar s. Leukemia. 2013 Jan;27(1):208-12. doi: 10.1038/leu.2012.189. Epub 2012 Jul 11. Leukemia. 2013. PMID: 22781594 Free PMC article.
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
Witzig TE, Laumann KM, Lacy MQ, Hayman SR, Dispenzieri A, Kumar S, Reeder CB, Roy V, Lust JA, Gertz MA, Greipp PR, Hassoun H, Mandrekar SJ, Rajkumar SV. Witzig TE, et al. Among authors: kumar s. Leukemia. 2013 Jan;27(1):220-5. doi: 10.1038/leu.2012.236. Epub 2012 Aug 20. Leukemia. 2013. PMID: 22902362 Free PMC article. Clinical Trial.
Will the real myeloma please stand up?
Kumar S, Rajkumar SV. Kumar S, et al. Leukemia. 2013 Apr;27(4):760-1. doi: 10.1038/leu.2012.359. Leukemia. 2013. PMID: 23575608 No abstract available.
Thalidomide as initial therapy for early-stage myeloma.
Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A, Fonseca R, Geyer SM, Iturria N, Kumar S, Lust JA, Kyle RA, Greipp PR, Witzig TE. Rajkumar SV, et al. Among authors: kumar s. Leukemia. 2003 Apr;17(4):775-9. doi: 10.1038/sj.leu.2402866. Leukemia. 2003. PMID: 12682636 Clinical Trial.
Expression of VEGF and its receptors by myeloma cells.
Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Fonseca R, Greipp PR, Rajkumar SV. Kumar S, et al. Leukemia. 2003 Oct;17(10):2025-31. doi: 10.1038/sj.leu.2403084. Leukemia. 2003. PMID: 14513053
31,689 results
You have reached the last available page of results. Please see the User Guide for more information.